Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Pear Therapeutics announced a deal with Sandoz to commercialize its two lead products, reSET and reSET-O.
read more
Wednesday, October 30, 2019
Pear Therapeutics has entered into an agreement with Ironwood Pharmaceuticals to evaluate PDTs for the treatment of selected indications within the GI space.
read more
Wednesday, August 03, 2016
PDS Life Sciences, a global provider of software and solutions for life sciences research and development, was selected to be the preferred provider of research data transformation services for a top-tier global biopharma company.
read more
PDS Life Sciences announced the appointment of Vicente Nogués, PhD, to vice president of product development effective May 2, 2017.
read more
PDS Biotechnology Corporation, a clinical-stage immunotherapy company developing a novel therapy for HPV-associated cancer based on the Company’s proprietary Versamune® T-cell activating technology, and the Head and Neck Cancer Alliance (HNCA) ...
read more
PDI, a global leader in infection prevention product and service solutions, announced the appointment of Firas Abulaban as Vice President of Quality. Quality assurance continues to be an area of significant investment for PDI in support of the ...
read more
PCR Biosystems announced the launch of qPCRBIO Probe 1-Step Virus Detect, a high-concentration 4x RT-qPCR kit designed specifically for ultra-sensitive, high-throughput detection of viral RNA sequences, including SARS-CoV-2.
read more
PCM Trials, and its subsidiaries EmVenio Research and Clinical Trial Service, are aligning under a single name – EmVenio Clinical Research. This consolidation brings together each company’s strengths under one entity to offer sponsors and contract ...
read more
Thursday, January 11, 2024
PCM Trials, a Denver, USA-based provider of mobile research nurses for decentralized clinical trials (DCTs), announced the acquisition of Clinical Trial Service (CTS).
read more
Global pharmaceutical outsourcing services provider PCI Pharma Services (PCI) is pleased to announce a laboratory expansion at its site in Tredegar, Wales, UK.
read more
Monday, September 17, 2018
PCI Pharma Services announced its exclusive collaboration agreement with CSP Technologies for U.S. clinical trials and stability testing utilizing Activ-Blister packaging solutions.
read more
PCI Synthesis announced the company’s president, Ed Price, has joined the Board of Governors of the Society of Chemical Manufacturers and Affiliates (SOCMA).
read more
Wednesday, December 26, 2018
Novacap announced that it will combine its Contract Development and Manufacturing Organization subsidiaries – PCI Synthesis, PCAS, Uetikon and Proteus – into a new entity to be known as SEQENS.
read more
Wednesday, April 20, 2016
PCI Synthesis, Inc. has announced the formation of its cGMP Advanced Polymer Development and Manufacturing Group, which is currently developing and manufacturing more than a dozen advanced polymer-based projects.
read more
PCI Pharma Services has announced a footprint expansion program at its site in Tredegar, South Wales. This latest expansion demonstrates continued investment in PCI Pharma Services’ Tredegar facility.
read more